• About Us
  • Contact
FNN
  • News Categories
    • Company News
    • Interviews
    • Market Reports
    • Stock Watch
    • Company Presentations
    • Funds Management
  • Funds Management
    • Acorn Capital
      • Acorn Capital Investment Fund
    • Altrinsic
      • Altrinsic Global Advisors
    • Antares
      • Antares Australian Equities Fund
      • Antares Dividend Builder
      • Antares Elite Opportunities Fund
      • Antares Fixed Income Fund
      • Antares Listed Property Fund
    • Ausbil
      • Ausbil 130/30 Focus Fund
      • Ausbil Active Sustainable Equity Fund
      • Ausbil Australian Active Equity Fund
      • Ausbil Australian Emerging Leaders Fund
      • Ausbil MicroCap Fund
    • Capital Property Funds
      • Capital Property Funds
    • Fairview
      • Fairview Equity Partners Emerging Companies
    • Hunter Hall
      • Hunter Hall Global Value
    • Intermede
      • Intermede Global Equities Fund
    • MLC
      • MLC Inflation Plus
    • Presima
      • Presima Global Property Securities Concentrated Fund
    • ResiFund
      • ResiFund
    • Ruffer
      • Ruffer
    • Russell Investments
      • Russell Investments
    • Tribeca Investment Partners
      • Tribeca Investment Partners
    • VanEck
      • VanEck
  • Expert Insights
    • Jeffrey Liu
    • Michael Gable
    • Patrick Taylor
  • Media Releases
  • Investor Events
    • FNN Events

Media Releases › SUDA Pharmaceuticals

View All SUDA Pharmaceuticals News


SUDA Management Changes

08 Nov 2019 11:03 AM


The US based business development role, headed by Andrew Curtis, will cease in 30 days time. This function will be assumed by the incoming CEO and the Company’s international business development will be serviced from Australia.

For more information, download the attached PDF. 

Download this document

Subscribe

Subscribe for our daily email digest

Company Directors

  • Dr Michael Baker (CEO)
  • Mr Joseph Ohayon (CFO)
  • Mr Paul Hopper (Executive Chairman)
  • Mr David Phillips (Executive Director)
  • Mr David Simmonds (Non-Executive Director)

Contact Information

  • (08) 6142 5555
  • http://www.sudaltd.com.au
  • Level 1, Unit 12, 55 Howe Street, OSBORNE PARK, WA, Australia, 6017

Latest Company News

Youfoodz (ASX:YFZ) posts strong quarter 2 growth and reaffirms prospectus forecast

3 hours ago

PointsBet (ASX:PBH) appoints Shaquille ONeal as Australian Brand Ambassador

3 hours ago

Ampol (ASX:ALD) successfully completes $300 million off-market share buy-back

4 hours ago

First patients dosed in Telix Pharmaceutical's (ASX:TLX) Phase 3 US trial

4 hours ago

Blackstone Minerals (ASX:BSX) in talks with Trafigura

3 days ago

Beacon Lighting Group (ASX:BLX) subfund to acquire WA showroom

3 days ago

Latest Media Releases

QEM - Quarterly Activities Report

2 hours ago

QEM - Quarterly Cashflow Report

2 hours ago

Nyrada Reports Further Results from Cholesterol Study

3 hours ago

Altech Chemicals - Battery Performance Tests Using HPA Coated Graphite

5 hours ago

Cyclopharm - Proposed issue of Securities

6 hours ago

Cyclopharm Capital Raising Presentation

6 hours ago

Cyclopharm Successfully Completes A$30 Million Placement

6 hours ago

SUDA Pharmaceuticals - Quarterly Appendix 4C and Activities Report

6 hours ago

SUDA Pharmaceuticals - Zolpimist Update

6 hours ago

Cyclopharm - SNMMI Requests USFDA to Expedite Approval For Technegas

3 days ago

Recent Insights

Growth Focus: Neometals Ltd (NMT)

17/12/2020 15:04

Post-Covid Wealth Management Strategy

17/12/2020 12:07

Jeffrey Liu

16/12/2020 12:40

Growth Focus: SRG Global Ltd (SRG)

05/12/2020 15:42

Growth Focus: New Century Zinc Ltd (NCZ)

09/11/2020 15:41

FNN

ABN 31 117 966 328
Disclaimer
Privacy Policy

Categories

  • Company News
  • Market Reports
  • Interviews
  • Presentations
  • Funds Management

Newsletter

Receive Daily News to your email

Recent Companies

  • ASX:ALD
  • ASX:ALL
  • ASX:CCL
  • ASX:LYC
  • ASX:FPH
  • ASX:WES
  • ASX:URW
  • ASX:APT
  • ASX:SOL
  • ASX:ANN
  • ASX:APT
  • Nasdaq:AFRM
  • ASX:PYR
  • ASX:PME
  • ASX:CUV
  • ASX:RSG
  • ASX:PNV
  • ASX:Z1P
  • ASX:AUB
  • ASX:BIN
  • ASX:BLX
  • ASX:BSX
  • ASX:CBA
  • ASX:WBC
  • ASX:FMG
  • ASX:BHP
  • ASX:OSH
  • ASX:WPL
  • ASX:CWN
  • ASX:AUK
  • ASX:CDV
  • ASX:CIP
  • ASX:NIC
  • ASX:COF
  • ASX:BLD
  • ASX:CWY
  • ASX:INR
  • ASX:MLT
  • ASX:CYC
  • ASX:PLS
  • ASX:WHC
  • ASX:PLL
  • ASX:DMP
  • ASX:NVX
  • ASX:DOW
  • ASX:TLS
  • ASX:GLL
  • ASX:NCM
  • ASX:TYR
  • ASX:NOX

Copyright Finance TV Pty Ltd All Rights Reserved

  • Home
  • News Categories
    • Company News
    • Interviews
    • Market Reports
    • Stock Watch
    • Company Presentations
    • Funds Management
  • Funds Management
    • Acorn Capital
      • Acorn Capital Investment Fund
    • Altrinsic
      • Altrinsic Global Advisors
    • Antares
      • Antares Australian Equities Fund
      • Antares Dividend Builder
      • Antares Elite Opportunities Fund
      • Antares Fixed Income Fund
      • Antares Listed Property Fund
    • Ausbil
      • Ausbil 130/30 Focus Fund
      • Ausbil Active Sustainable Equity Fund
      • Ausbil Australian Active Equity Fund
      • Ausbil Australian Emerging Leaders Fund
      • Ausbil MicroCap Fund
    • Capital Property Funds
      • Capital Property Funds
    • Fairview
      • Fairview Equity Partners Emerging Companies
    • Hunter Hall
      • Hunter Hall Global Value
    • Intermede
      • Intermede Global Equities Fund
    • MLC
      • MLC Inflation Plus
    • Presima
      • Presima Global Property Securities Concentrated Fund
    • ResiFund
    • Ruffer
    • Russell Investments
    • Tribeca Investment Partners
    • VanEck
  • Expert Insights
    • Jeffrey Liu
    • Michael Gable
    • Patrick Taylor
  • Media Releases
  • Investor Events
    • FNN Events